This article is more than 5 years old. Information may no longer be current.
University of Michigan Cancer Center names associate director
Click Here to Manage Email Alerts
Bhramar Mukherjee, PhD, has been appointed associate director for population science research at University of Michigan Comprehensive Cancer Center.
Mukherjee is John D. Kalbfleisch collegiate professor of biostatistics and professor of epidemiology at the university’s School of Public Health. She also serves as the associate chair for biostatistics.
Bhramar Mukherjee
In her new role, she will oversee the cancer center’s research on cancer screening, detection and prevention, as well as research on cancer outcomes, disparities and new models of cancer care delivery.
“I am so impressed with Dr. Mukherjee,” Theodore S. Lawrence, MD, PhD, director of the cancer center, said in a press release. “She is a stellar researcher in biostatistics, epidemiology and disparities. These are key issues for our Cancer Center to address. We have tremendous strength and talent in our population science program, and I am thrilled to bring in Dr. Mukherjee to lead it.”
Mukherjee joined the University of Michigan faculty in 2006. Her cancer research has focused on how the interaction between genes and the environment impacts cancer risk. She has studied the roles of diet, physical activity and lifestyle factors, and their interplay with the genetic architecture of an individual. She also has worked on models to predict cancer risk among people with known genetic risk coming from high risk families.
“As a biostatistician and epidemiologist, I can bring a lot to this role,” Mukherjee said in a press release. “We live in a very data-driven world. There are tremendous opportunities, both within the University of Michigan and nationally around big data, using medical records and mining large datasets to manage patient outcomes and care. Groundbreaking prevention and health communications research is happening today by using social media and mobile sensors. Data is helping us to better understand disparities in cancer care, delivery and outcomes.”